Hee-Jeong Im

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Knee Osteoarthritis

Anti Inflammatory Drugs

Vascular Endothelial Growth Factor

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kaige Ma, Tiep Pham, Jun Wang, InSug O-Sullivan, Amy DiCamillo, Shiyu Du, Fackson Mwale, Zeba Farooqui, Gina Votta-Velis, Benjamin Bruce, Andre J van Wijnen, Ying Liu, Hee-Jeong Im
Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage. Science advances 10 (7) (2024)
Kaige Ma, Tiep Pham, Jun Wang, InSug O-Sullivan, Amy DiCamillo, Shiyu Du, Fackson Mwale, Zeba Farooqui, Gina Votta-Velis, Benjamin Bruce, Andre J van Wijnen, Ying Liu, Hee-Jeong Im
Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage. Science advances 10 (7) (2024)
Kaige Ma, Tiep Pham, Jun Wang, InSug O-Sullivan, Amy DiCamillo, Shiyu Du, Fackson Mwale, Zeba Farooqui, Gina Votta-Velis, Benjamin Bruce, Andre J van Wijnen, Ying Liu, Hee-Jeong Im
Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage. Science advances 10 (7) (2024)
Praneet Dara, Zeba Farooqui, Fackson Mwale, Chungyoul Choe, Andre J van Wijnen, Hee-Jeong Im
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases. Biomedicines 11 (6) (2023)
Praneet Dara, Zeba Farooqui, Fackson Mwale, Chungyoul Choe, Andre J van Wijnen, Hee-Jeong Im
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases. Biomedicines 11 (6) (2023)